A case of phaeochromocytoma with hypokalaemia, hyperaldosteronism, normal cortisol production and normal urinary corticosteroid excretion is described. Both \g=a\-adrenergic blockade and combined \g=a\and \g=b\ blockade resulted in marked antidiuresis with urinary sodium and potassium retention and a rise in plasma volume. Combined \g=a\and \g=b\ blockade led to some reduction in the high aldosterone production rate. The hypokalaemia was corrected by \g=a\-adrenergic blockade. After operative removal of the tumour the aldosterone production rate was normal.
INTRODUCTION
In patients with a phaeochromocytoma the plasma volume and red cell mass may be abnormal (Brunjes, Johns & Crane, 1960; Sjoerdsma, Engelman, Waldman, Cooperman & Hammond, 1966 ) and a-adrenergic blockade results in antidiuresis (Corcoran, Dustan & Page, 1956 ) and expansion of plasma volume (Ross, Prichard, Kaufman, Robertson & Harries, 1967) . Urinary and plasma electrolyte changes in response to combined a-and /^-adrenergic blockade in patients with phaeochromo¬ cytoma do not appear to have been reported.
Interrelationships of adrenal medullary and cortical activity in phaeochromocy¬ toma have been described in a number of reports (Cope, Labbe, Raker & Bland, 1952;  Williams, Crockett, Butler & CrispeU, 1960; Walters, Wyatt & Kelleher, 1962; Liddle, Island, Ney, Nicholson & Shimizu, 1963) . Aldosterone excretion has rarely been estimated in such patients but when reported has usually been normal (Ross, 1959; Ramsey & Langlands, 1962) . One report of excess aldosterone excretion was in a patient who also had excess corticosteroid production (Bourgoignie, Dupont & In this paper we describe studies in a patient with a phaeochromocytoma who appears to be unique in having excess aldosterone production with normal cortisol production. The 
Metabolic studies
The patient was maintained on a diet containing 10 mequiv. sodium/day with an additional 5 g sodium chloride as capsules given in divided doses. Twenty-four hour collections of urine were made from 10-00 h to 10-00 h and analysed for sodium and potassium using an Eppendorf flame photometer. Endogenous creatinine clearances were determined over 24-h periods, the creatinine being measured in an autoanalyser. Plasma volume was measured by means of 125I-labelled albumin. Aldosterone pro¬ duction rate was measured by the method of Brooks (1960) . The effects of a-adrener¬ gic blockade and of combined a-and /^-adrenergic blockade on plasma and urinary electrolytes, aldosterone production rate and plasma volume and renal function were studied.
RESULTS
The results are shown in Figs 1 and 2 and in Table 1 . On a low sodium diet ( Fig. 1 ) the patient came into balance by the 3rd day but the sharp rise in blood urea and the fall in creatinine clearance suggest that a fall in G.F.R. played a significant part in this.
In the control period of this study and the subsequent one, there was an appreciable fluctuation in the urinary sodium excretion as is frequently seen in hypertensive patients. Since this patient sweated considerably, this no doubt contributed to the variation in urinary sodium excretion. The administration of phenoxybenzamine led to a precipitous fall in the urinary sodium excretion ( Fig. 2 ) but this rose despite continuing administration of the drug. Similarly the urinary potassium fell for 4 days and then rose again. This potassium retention was associated with a rise in plasma potassium but no rise in blood urea or fall in creatinine clearance. This suggests that there was either a decrease in the delivery of sodium to the distal tubule where sodium and potassium are exchanged, or a fall in aldosterone produc¬ tion or both.
When phenoxybenzamine was given in much larger dosage together with propranolol, the urinary sodium fell sharply and remained at a low level so long as the drugs were continued (Fig. 2) . The excretion of potassium also fell but the plasma level fluctuated around the level of 3-0 mequiv./l. With the combined a-and ß-adrenergic blockers there was a rise in blood urea which was probably due to the ß blocker because the rise began during the administration of propranolol alone. This resembles the findings during the treatment with a low sodium diet; again the creatinine clearance fell, reaching its lowest value of 12 ml/min.
The aldosterone production rate was initially determined while the patient was on a sodium intake of 95 mequiv./day and it was extremely high at 685 /¿g/day (normal range 70-200 /ig/day on an intake of 100 mequiv. sodium/day). At this time the plasma volume was 2-2 litres and the calculated blood volume 3-1 litres ( Postoperative progress was uneventful and 7 weeks after the operation the patient's blood pressure was 160/80 mm Hg, urinary VMA was 5-1 mg/day, plasma potassium was 3-9 mequiv./l, haemoglobin was 15-2 g/100 ml and the haematocrit 45%. She was feeling very much better than before the operation, had gained 5-5 kg in weight but had developed mild bilateral ankle oedema. (Mathison & Waterhouse, 1969) appeared to lead to increased secretion of both catecholamines and corticosteroids. In the few cases of phaeochromocytoma for which aldosterone data are available, values have been normal (Ross, 1959; Ramsey & Langlands, 1962; Liddle et al. 1963 ) except in one case in which increased aldosterone secretion was associated with increased corti¬ costeroid production leading to Cushing's syndrome (Bourgoignie et al. 1964 (Ames, Borkowski, Sicinski & Laragh, 1965) . The reduction in aldosterone production during combined a-and /?-adrenergic blockade may have been related to the observed sodium retention and rise in plasma volume. Another possibility is that adrenergic blockade led to reduction in plasma renin and hence in aldosterone production. Ganong (1972) has summarized evidence that the sympathetic nervous system increases renin secretion by way of a /^-adrenergic receptor mechanism, and that the increase in plasma renin induced by increasing plasma catecholamine levels may be potentiated by a-adrenergic blockade and is abolished by /?-adrenergic blockade. Plasma renin has been found to be increased in some cases of phaeochromocytoma (Werning, Zeigler, Baumann, Endres, Gysling, Weidman & Seigenthaler, 1970) .
Unfortunately in the present case no determination was made of the aldosterone production rate with a-adrenergic blockade alone. After removal of the tumour there was no evidence of aldosterone deficiency and subsequently the production rate was normal. This contrasts with the situation usually seen after removal of an aldosterone-secreting tumour. Although the red cell mass was not directly determined, calculation indicates that it was markedly reduced, and so the total blood volume would also be low and this should tend to stimulate aldosterone production.
In rare cases of phaeochromocytoma associated with bilateral adrenal cortical hyperplasia it seems likely that the tumour is producing a corticotrophin-like material (Liddle et al. 1963 ). This might lead to a temporary increase in aldosterone production but would also lead to increased corticosteroid production.
The possibility that the tumour itself secreted aldosterone cannot be entirely excluded as no incubation or extraction procedures were carried out.
A further theoretical possibility is that the tumour may have been producing some substance other than adrenaline or noradrenaline, which stimulated aldo¬ sterone production. Plasma volume and total blood volume were low in our patient and plasma volume rose during a-adrenergic blockade, and during combined and ß blockade. Patients with hypertension have an increased tendency to excrete sodium and their plasma volume covers a much wider range than normal, some being above normal and some being below (Jones, Clapham, Barraclough & Mills, 1964) . This patient may represent one extreme of the range found in hypertensive patients. Blood volume has been found to be low in some but not all cases of phaeochromocytoma (Brunjes et al. 1960; Sjoerdsma et al. 1966 ). Infusion of adrenaline (Kaltreider, Meneely & Allen, 1942) or of noradrenaline (Finnerty, Buckholz & Guillaudeu, 1958) lead to reduction in plasma volume. The plasma volume rises during a-adrenergic blockade both in phaeochromocytoma (Ross et al. 1967) and in normal subjects (Weil & Chidsey, 1968 Hypokalaemia is not a usual feature of phaeochromocytoma though it has been noted in cases associated with high corticosteroid production. Cortisol production was normal in our patient, but aldosterone production was high and presumably played a part in the development of the hypokalaemia. The very high catecholamine output of the tumour may also have influenced the plasma potassium level. Shortterm infusion of adrenaline has been shown to induce hypokalaemia (Jacobson, Hammarsten & Heller, 1951) , an effect which may be blocked by propranolol (Massara, Tripodina & Rotunno, 1970) , while noradrenaline may cause a rise in plasma potassium (Ross, 1961) .
In our patient there was reduction in urinary sodium and potassium output during blockade, a rise in plasma potassium and no great change in G.F.R. This suggests that a-adrenergic blockade led to either reduced distal tubular sodium load and hence to conservation of potassium despite hyperaldosteronism, or a fall in aldo¬ sterone production, or both. With combined and ß blockade there was again a re¬ duction in urinary sodium and potassium excretion, and a modest reduction in the high aldosterone production rate, but hypokalaemia persisted. However, there was some diarrhoea at this time and faecal potassium loss may have increased.
Experimental studies of the effects of catecholamines on urinary composition have shown considerable variation in response depending on the nature of the catecholamine, dose levels, route and duration of administration, and sodium status of the subject. Thus short-term infusion of adrenaline (Smythe, Nickel & Bradley, 1952) or of noradrenaline (Nickel, Smythe, Papper & Bradley, 1954) in the dog led to reduction in urinary sodium and potassium output. With more long-term infusion in man, Laragh (1962) , Tuttle (1962) and Ames et al. (1965) showed that noradrenaline induced a small natriuresis and that this effect was more marked in sodium-depleted subjects. Green & Sim (1961) demonstrated that both adrenaline and noradrenaline could induce natriuresis in rats, and that pretreatment with phenoxybenzamine greatly reduced the diuretic effect. Pearson & Williams (1968) showed in dogs that noradrenaline administered into the left renal artery had a direct sodium-retaining effect on the kidney, and that the natriuresis induced by systemic administration of noradrenaline seemed to depend upon increased systemic arterial blood pressure and a concentration with minimal direct renal actions. They also showed that isoprenaline, having a /^-adrenergic action, induced natriuresis by a direct renal action, though administration of isoprenaline into a peripheral vein produced sodium retention.
In our patient the situation was made more complicated by the fact that presum¬ ably both noradrenaline and adrenaline were circulating in excess. In view of the antidiuresis induced by adrenergic blockade it seems reasonable to assume that the overall effect of the excess (Leiser & Corcoran, 1956 ). The urinary electrolyte effects during adrenergic blockade in phaeochromocytoma do not appear to have been reported before, and do not occur during administration of a-adrenergic blocking drugs to patients with essential hypertension (Craig, G. M., unpublished observations).
